ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[SPARC, SERPINE1, FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, SEMA6A, HSPG2, DCN, COL4A2, HGS, CX3CR1, THBS2, THBS1, E2F2, SEMA4A, TGFB2, PLK2, TIE1, KLF4, SULF1, PML, CXCL10, TEK, PF4]
GO:0045408;regulation of interleukin-6 biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;154.99429437694414;7.069023426578259;0.005187519546987567;0.7124295520356204;[TLR1, GHSR, NLRP12, CEBPB, IL1B, INPP5D, PTAFR, CARD9, TLR6, EREG]
GO:0007252;I-kappaB phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.292166977892469;0.006049650283656873;0.747921758369865;[CHUK, TLR7, TLR4, TLR2]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, AP1S2, HOMER3, CUBN, PRKCB, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, F2RL1, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0032691;negative regulation of interleukin-1 beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;6.781341354126479;0.002875903446815721;0.6977174774718518;[GHSR, NLRP3, TNFAIP3, ARRB2, PML]
GO:0051928;positive regulation of calcium ion transport;8.0;0.7043150770688792;0.7271575385344395;8.848365694942547;69.31158403183679;5.085725745451326;0.002319796341169766;0.6350842511328143;[CXCL9, ARRB2, MYLK, LGALS3, JPH2, PDGFRB, TRPC3, TRPC1, F2R, ATP1B1, XCL1, KCNE3, THY1, CD19, CCL5, CCL4, PLCG2, CCL2, PLCG1, SNCA, CCR1, WFS1, CAV1, CXCL10, P2RX5, CD4, CXCL11, EHD3, CXCL12, CALM3, F2RL3]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[ORM1, FZD5, RIPK2, NOD2, PYCARD, NLRP12, TLR8, NLRP3, CCL19, TLR4]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, IL18, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, EIF2AK2, NLRP12, CD27, IL18R1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, ICAM1, PYCARD, TNFSF11, TRIM25, PRKCH, PRKCB, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, RIPK2, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[CD6, TLR6, NOD2, TLR4, MYD88, IL17A]
GO:0042534;regulation of tumor necrosis factor biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.523163736834295;157.07373591862395;6.832634648514029;0.005257116584011703;0.7003406189322132;[IL10, GHSR, CARD9, CYBB, LILRB1, AZU1, THBS1, TLR1, BCL3, TLR4, CCR2]
GO:0060765;regulation of androgen receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;43.64299748026755;6.518977089658987;0.0014606918495168463;0.6843001567857983;[KDM5D, RNF6, ARRB2, SIRT1, DAB2]
GO:0042535;positive regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;857.3444905607055;7.379178354882098;0.028694548539119222;0.7523715242355574;[TLR1, CYBB, AZU1, TLR4, THBS1, CCR2]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, RIPK2, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, DDX58, RIPK2, HSPD1, MMP12, IFIH1, IRF7, TLR8, TLR7, TLR4]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, HDAC2, TGFB1, MYB, F2R, IHH, ARRB2, ENG, CTGF]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, IFIH1, DDX58, RIPK2, IRF7, TLR8, TLR7, TLR4, TLR2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, RIPK2, SLC11A1, PDE4D, IL18, IL23A, IL1B, LTA, TLR8, IRF8, TLR7, TLR4, TXK, EBI3, RASGRP1, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0014739;positive regulation of muscle hyperplasia;8.0;1.0;0.875;9.628524252492122;117.65934785475751;9.777073627680469;0.003937952486160401;0.875;[AIF1]
GO:2001204;regulation of osteoclast development;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;200.3946012839482;7.292166977892469;0.006707026961541477;0.769162383550154;[TYROBP, TNFSF11, LILRB1, LTF, FBN1]
GO:0018158;protein oxidation;7.0;0.7866048967936545;0.7442218136540277;9.265618758802754;161.09293151659517;7.292166977892469;0.005391635443634599;0.7238411236270654;[GPX1, LOX, LOXL1, LOXL2]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[IL10, CD274, CD96, IL33, NR1H4, LILRB1, INHBA, PDCD1LG2, GATA3, RARA, XCL1, TLR4, HAVCR2]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, CD74, IL33, POSTN, RIPK2, EIF2AK2, AZU1, MIF, ADCYAP1, IL1A, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, AP1S2, HLA-DOA, HLA-DOB, CTSD, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, KIF4A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, RIPK2, GMIP, SIRT1, DUSP6, PTAFR, NRAS, STAT4, DMD, PKN1, LGR4, CTGF, SESN3, MAP3K8, KCNH1, KCNH2, CISH, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, G3BP2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, TNFRSF1B, SPTB, LCP2, LCP1, DTL, BIRC2, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, PIK3R5, RACGAP1, CD14, PAG1, CCR1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR3, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, RELB, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, PLEK, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKCZ, PLCG2, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, HCLS1, PLCB1, HBEGF, EXOC1, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, CALCRL, CUL5, ITPR3, RASAL2, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, BCL2, CSPG4, LAT, BCL2L1, PIK3C2A, TREM1, TLK1, GPX1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, PDE4D, TGFBR3, ZAP70, DOCK2, CAMK2D, NCAM1, TSHR, PIKFYVE, RPS6KB1]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, RIPK2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, HLA-E, FGR, IL6, LTA, MYD88, TLR2]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, NLRC3, ARRB2, GPNMB, CD34, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, LILRB1, IRAK3, BCL3, RARA, BPI, TLR4, GPR18]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, CSF3, IFNA2, ARRB1, ARRB2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, RIPK2, MIF, SFRP2, IFNG, HCLS1, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, OSM, IL6, BCL2, CAMK1]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, ICAM1, HMOX1, GPX1, DAPK1, TNFRSF10B, SFRP2, BCL2L1]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[GREM1, SFRP4, SYK, EGF, FMR1, NTF3, PLCG2, ARRB1, ARRB2, SELE]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[GPX1, PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, KLF4, MAPK13, COL1A1, FABP1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0045416;positive regulation of interleukin-8 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.474488534686424;0.027942676825076673;0.7572456912631272;[TLR8, TLR7, TLR4, TNF, ELANE]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, NLRC3, ARRB1, ARRB2, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, ITGA4, CCL20, CXCL13, AIF1, PYCARD, CXCL10, CXCL12, CCL5, XCL2, XCL1, ADAM8, CCR2]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[C3, FCER1G]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, LRRK2, NOD2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ACHE, CALCRL, LRP1, TFRC, ITGB2, ADM, ARRB1, ARRB2, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, RAB31, NEDD4, CD9, RAMP1]
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;60.1825293085583;7.069023426578259;0.002014255095197483;0.6846304993685643;[CALCA, CXCL12, ARRB2, EPHB1]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[LYN, PDGFRA, FCER1G, SYK, TXK, PRKCD, PLEK, PDGFA, ALOX12, SELP, THBD, CEACAM1, PDPN, CD9, PRKCQ, TLR4]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GPX1, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, IRF7, TLR6, CD14, TLR4]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[ITGB5, ARRB1, AIF1, EPS8, PLS1, ACTN1, PAWR, ACTN4, SORBS1, MARCKS, ZYX, LCP1]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, ARRB2, KLF4, SIRT1, PKHD1, BANK1, AKT1, EPHA2]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, AIF1, ICAM1, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:1902176;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;10.0;0.8653626801206646;0.8479223519212526;9.600353375525426;999.3623287810346;6.781341354126479;0.033447757776597226;0.7620391240755716;[GPX1, SOD2, SIRT1, VNN1, AKT1]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC6, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG2, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[CYFIP1, CD3G, IGHG1, FCGR3A, FCGRT, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, CLEC4D, CLEC4E, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, CYP1B1, IL6R, DAPK1, PRKCD, MSH6, MELK, MSH2, IFI27, LGALS12, BTK, EPHA2, CUL5, LY96, TNFRSF11A, TP53BP2, HMOX1, SFN, CD14, TGFB2, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, BCL3, CD28, BCL2, CD27, CD24, BCL2L1, CDKN1A, CD40, FASLG, BRCA1, BRCA2, CD3E, CD38, GPX1, DCC, PAWR, TNFRSF1B, SIRT1, IL1A, IFNG, IL1B, TLR4, PPP1R15A, CEBPB, BCL2A1, IFI6, PERP, E2F1, E2F2, CASP8AP2, IL33, SORT1, G0S2, GZMB, MLH1, POU4F1, PML, GZMH, CD5]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FMR1, XPO1, AKT1, SLC11A1, PRKCD, AXIN2, E2F1, RBM38, TNFSF13, MAPK14, MYD88]
GO:0042311;vasodilation;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;40.37281764308888;6.599019797332524;0.0013512418733372556;0.712474179321389;[CALCA, EDNRB, GPX1, GCH1, ADRB2, SOD2]
GO:0043523;regulation of neuron apoptotic process;7.0;0.7043150770688792;0.7030769037916401;8.763526815005518;34.538657273781794;4.5143834387755835;0.0011559777761799947;0.581785144256483;[MYB, MEF2C, F2R, CDC34, MSH2, ADAM8, NAIP, C5AR1, GATA3, SLC30A10, CORO1A, HMOX1, NAE1, JUN, TGFB2, WFS1, NR4A2, NR4A3, BCL2, UBE2M, BCL2L1, NRP1, BTG2, CTSZ, FASLG, ARRB1, ARRB2, CHL1, GPX1, IL1B, CEBPB, LRP1, NTF3, CCL2, FYN, SNCA, GABRA5, SOD2, POU4F1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, RELB, PAK1, NRAS, KLRK1, PLCG2, MUC13, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11]
GO:0043403;skeletal muscle tissue regeneration;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;44.68137006025916;7.004484905440688;0.0014954452452945145;0.6484506956670166;[GPX1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3, RPS6KB1, NOX1]
GO:0007628;adult walking behavior;4.0;1.0;0.75;9.628524252492122;34.938319875750295;6.518977089658987;0.0011693541237948906;0.5833807915285978;[ABHD12, ARRB2, SCN1A]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, PLEK, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0001885;endothelial cell development;5.0;0.8259837884571596;0.7032329060895001;9.176539128749065;34.35043118565193;6.444869117505266;0.0011496780184027697;0.6198319182472036;[PPP1R16B, GPX1, PDE4D, F11R, ICAM1, F2RL1]
GO:0031338;regulation of vesicle fusion;6.0;0.7248374789738407;0.6855390520770648;8.935377071932177;48.20117096329211;5.514393750639154;0.0016132498139038735;0.6051266654433651;[CORO1A, TMEM27, EVI5, ANXA1, TBC1D8, TBC1D9, TBCK, VPS41]
GO:0071673;positive regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;372.1937940336002;8.67846133901236;0.012456991333636938;0.8400575416471059;[PDGFD, AIF1]
GO:0032707;negative regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[TLR4]
GO:0045671;negative regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;842.5336305879634;6.481236761676141;0.028198842384740134;0.7276913745807394;[LILRB1, LILRB3, LILRB4, MAFB, INPP5D, TLR4, LTF, FBN1]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, TNFAIP3, AIF1, CNN1, HMOX1, IL10, MEF2C, PTGIR, MYOCD, IGFBP5, IGFBP3, TPM1, KLF4, SOD2, IFNG, OGN, TRIB1]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:0071672;negative regulation of smooth muscle cell chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;373.36881743152423;8.390779266560578;0.012496318309313052;0.8253454670833372;[AIF1]
GO:0033599;regulation of mammary gland epithelial cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;45.58987593597882;6.8867018697843045;0.0015258521193526465;0.6753065664753021;[MED1, GPX1, GATA3, BRCA2, IQGAP3, PHB2, HOXA5]
GO:0071315;cellular response to morphine;8.0;1.0;0.875;9.628524252492122;528.974071528598;8.390779266560578;0.017704286128305307;0.8041048419030481;[AIF1]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, NCKAP1L, TLR4]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, ICAM1, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HCLS1, HBEGF, CSF1R, HDAC2, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, GH1, CD4, IL6, CSPG4, CD24]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, FAM105A, USP1, IL33, USP9Y, PSMC6, TNIP3, PSMC2, EIF3F]
GO:0033194;response to hydroperoxide;4.0;0.7980440201809971;0.6490220100904985;9.34084218004034;25.335607989987928;6.781341354126479;8.479599988580431E-4;0.5967981122146513;[GPX1, CHUK, DAPK1, PRKCD, MGST1, AIF1, CD38, CD36]
GO:0090201;negative regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.8116675549172;6.943860283624253;0.015824581010188264;0.7513499630073597;[GPX1, AKT1, ARRB2, CLU, BCL2L1]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0043534;blood vessel endothelial cell migration;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;26.070480469920426;6.599019797332524;8.725555194190899E-4;0.712474179321389;[GREM1, NR4A1, NRP1, EGR3, GPX1, ID1, EMP2]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, RIPK2, BTK, TLR8, TLR7, TLR4, CARD11, BIRC2, BIRC3, LY96, NLRC3, RELB, CD14, CARD9, NFKB1, NFKB2, NFKBIA, BCL3]
GO:0045953;negative regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.6560499367194;7.379178354882098;0.014447139526158352;0.7736121494158466;[CEACAM1, CLEC12B, LILRB1, SERPINB9, ARRB2, HAVCR2, HLA-E]
GO:0002862;negative regulation of inflammatory response to antigenic stimulus;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;271.2297480501572;7.379178354882098;0.009077815576313241;0.7523715242355574;[IL10, ADCYAP1, GPX1, FCGR2B]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, AIF1, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, TWIST1, THY1, PRKCZ, SAMSN1, FLRT2, PRKAR2B, SFN, LYN, JUN, PLK1, LIF, NR2F2, CALM3, PKIG, CDKN1A, PTPRR, LRRC4, TIMP3, DUSP2, DUSP3, DUSP1, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, PODN, NLRP12, F2RL1, PKN1, PYCARD, MEN1, CISH, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, CDK6, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, PDE4D, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, EIF2AK2, CDC6, AZU1, NOX4, NOX1, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, RIPK2, FCRL3, EMP2, SIRT1, DUSP6, CKS2, HCLS1, PLCB1, HBEGF, ENG, CCL13, FAM129A, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CSF3, CCNT2, NCF1, FMR1, TNF, CLU, CTGF, PYCARD, MAP3K8, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, DAB2, PTPRC, CDK1, BCL2, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, ARRB1, ARRB2, CYR61, XCL2, XCL1, LCP2, HDAC2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, CCNC, ICAM1, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, PIK3R5, SLAMF1, CCR1, EGR1, LIF, PTK2, MARCO, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, STRADB, IL18, PARP9, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, AIF1, GNAI2, PAK1, CD74, OSM, CD40LG, F2RL1, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, RASGRP1, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PDE4D, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0032497;detection of lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;150.00497270670016;8.390779266560578;0.005020531440782482;0.7522251544931926;[LY96, TREM2, TLR4]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[CYFIP1, HACE1, RHOG, AIF1, EPS8, RAC2, RHOU]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[FGR, FCER1G, SYK, GAB2]
GO:0034392;negative regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.11293359827955;7.9853141584524145;0.004254355493321279;0.8046099625986299;[EDN1, ARRB2]
GO:0061136;regulation of proteasomal protein catabolic process;9.0;0.6763753087927167;0.7344282795766475;9.060540214886183;224.62789392231474;4.60092389510664;0.007518093457600162;0.6315320871408845;[FMR1, CLU, LAMP3, AKT1, TRIB1, PSMD14, OSBPL7, PLK2, CAV1, PLK1, DAB2, LRRK2, ALAD, GPX1, CBFA2T3, RNF144B, CEBPA, TAF9, IL33, PSMC6, PSMC2]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[IL6, RIPK2, C5AR1, CARD9, NLRP3, TREM2, IRAK3, NOD2]
GO:0032495;response to muramyl dipeptide;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;59.66765988983927;7.004484905440688;0.0019970228791053504;0.6813299963962409;[JAG1, RIPK2, CARD9, TNFAIP3, PTPN22, NOD2, MAPK14, NFKBIA]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, IL33, SUCNR1, TYROBP, SYK, PRKCE, HAVCR2]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, ARRB2, F11R, CDH5, FOS, SIRT1, TGFBR3, ADAM9, LTBP2, PRKCZ, JUN, TGFB2, TGFB1, USP9Y, PTK2, PML, COL3A1, COL1A2, ID1, ZYX]
GO:0007212;dopamine receptor signaling pathway;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;26.976932752798508;6.166155715036245;9.028936615729279E-4;0.6384578026126634;[GNA15, GNAQ, FLNA, ARRB2, DRD4]
GO:0006641;triglyceride metabolic process;7.0;0.8436909121759173;0.7727648213451592;9.318369324188282;85.59385656069774;5.500407508664414;0.0028647493496168257;0.6322104610454062;[SLC22A4, MOGAT2, NKX2-3, DGAT2, GPX1, ACSL1, CAV1, SIRT1, FABP1, FABP7]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[STEAP4, FFAR2, MED1, GPX1, SIRT1, PLCB1, CEBPA, CEBPB, RETN, ADRB2, PTGS2, FOXO1, PRDM16, EGR2, LAMB3, NOC3L, KLF4, NR4A2, NR4A1, ALDH6A1, LRG1, NR4A3]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[, NUP107, PHB2, AP1S2, AKT1, HOMER3, WLS, ZFYVE16, NUP85, NUP88, SRP9, MMP12, SNX17, NCF1, CSE1L, TNF, CLU, LAMP2, AP2M1, RAB32, RAB31, SLC27A2, EVI5, BCL6, BCL3, TLK1, ARL4C, NLGN1, UNC93B1, RAB21, PML, VPS41, IFIT1, ARFIP1, SEC63, EGR2, POLA2, CD24, AKAP12, XPO1, TMED6, SYK, STRADB, RAB33B, NAPA, HSD17B4, STX11, RANBP2, RANBP1, CD74, RANBP6, NEDD4, NUPL2, RAMP1, SCARB2, ZFAND6, TSC2, ATP1B1, HGS, COPB2, LTBP2, TGFB1, NUP155, NFKBIA, TBCK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, IFNG, EHHADH, NUP54, HSPD1, NUP35, RAN]
GO:0042699;follicle-stimulating hormone signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;62.84085921303097;8.16763571524637;0.002103227004758593;0.7408135829017477;[LHCGR, ARRB1, ARRB2]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, IL10, ANXA1, FCER1G, SYK, PDE4D, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK, P2RX1]
GO:1902905;positive regulation of supramolecular fiber organization;6.0;0.6799073451904818;0.6630739851853854;8.529911963824013;65.83631000230255;4.551326953967268;0.0022034820469448244;0.5558753846743789;[CYFIP1, CSF3, CLU, CTGF, ICAM1, PYCARD, PRKCE, TPM1, PFN1, NCKAP1L, VASP, VIL1, FES, JMY, ID1, NOX4, NRP1, PLEK, LMOD1, ARHGEF10L, CCR7, EDN1, GPX1, HCK, PSRC1, SYNPO2, PAK1, FLNA, GSN, CCL21, F2RL1]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0060729;intestinal epithelial structure maintenance;8.0;1.0;0.875;9.628524252492122;27.01847773359651;8.390779266560578;9.042841346921817E-4;0.8041048419030481;[TLR4]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL10, IL33, ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, ARRB1, BRCA1, ARRB2, BMI1, CDC20, SKP2, RIPK2, BIRC2, BIRC3, ADRB2, NOD2, FANCI, NDFIP2, WFS1, UBE2C, CAV1, PLK1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, MX2, CARD9, LILRB1, PML, F2RL1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, RIPK2, CYBB, MIF, HLA-E, TLR1, IL23A, TLR4, TLR2, HDAC2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[TNFAIP3, ARRB1, ARRB2, AKT1, FBXO5, SOX4, PRKCE, FYN, CAV1, ISG15, MAD2L1]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G, NR4A3]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[LRRK2, ARRB1, ARRB2, F11R, KLRK1, PDE6D, RHOH, GMIP, ADCYAP1]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[GFI1, TNFAIP3, ARRB1, ARRB2, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, NLRC3, PKHD1, G3BP2, NLRP3, NR1H4, KLF4, NFKBIA, NLRP12, CCDC22, NFKBID]
GO:0090026;positive regulation of monocyte chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;859.35541097108;6.8867018697843045;0.028761852235543582;0.7674272657460779;[CCR1, CXCL10, CXCL12, CCL5, SERPINE1, CCL1, FPR2, S100A14, PLA2G7, AIF1, CCR2]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[EOMES, SEMA4A, FCER1G, LEF1, RORA, GATA3, RELB, CLEC4D, BCL3, CLEC4E, IL18R1]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, RIPK2, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, TNIP3, S100A14, CD14, TLR4]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[TXNDC15, GPX1, SLC11A1, TMX1]
GO:1903974;positive regulation of cellular response to macrophage colony-stimulating factor stimulus;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;111.61630484940933;8.67846133901236;0.0037356972751570123;0.7947362817240173;[TLR4, TLR2]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, EBI3, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;7.9853141584524145;0.004698449899916962;0.7592887026755414;[CD36, TLR6, TLR4]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, HLA-E, CLEC4D, SLPI, IL23A, CLEC4E, S100A9, S100A8, SEH1L, C5AR1, CFP, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, RIPK2, TLR1, FGR, IGHD, LTA, IRF8, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ARRB1, ARRB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, TMPRSS2, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:0042744;hydrogen peroxide catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;235.80375524332874;6.481236761676141;0.007892139478392308;0.6545710619905948;[HBZ, GPX1, MPO, PXDN]
GO:0048298;positive regulation of isotype switching to IgA isotypes;11.0;1.0;0.9324289523296623;9.628524252492122;1407.9016349495496;8.16763571524637;0.04712120069255247;0.8501222226412654;[TGFB1, MSH2, TNFSF13, MLH1]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[GREM1, MEF2C, MYOCD, EDN1, TGFB1, ARRB2]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[SPI1, EHMT2, SLA2, AKT1, MEF2A, MEF2C, ATF3, GATA3, IQGAP3, GATA1, HESX1, JUN, EIF2AK2, NR2F2, PKIG, EZH2, SIRT1, SRP9, MMP12, BTAF1, FLNA, CENPF, LGR4, GMNN, CTGF, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, LRRK2, FHL2, PIK3CD, FASLG, HHEX, ITGB8, PEG3, BIRC5, BIRC2, BIRC3, UHRF1, E2F1, FYN, E2F7, PRRX1, EIF3E, IKZF1, UXT, HNF1B, MIF, EREG, SFRP2, IFI27, KCNQ1, NAIP, GSPT1, PCBP3, A2M, CCR1, EGR1, MSR1, ID1, CD28, SUV39H1, CTSZ, PTPRK, BRCA1, CD3E, BMI1, CD38, CD36, CD34, BANK1, IL1B, DEPDC1, SATB2, RELB, RXRA, NEDD4, LOXL2, EOMES, CCNE1, CALCA, TCF7, CCNB1, VDR, CAV1, HMGA1, BMP2, UBA3, MXD1, HMGB2, MYOCD, NCBP2, GREM1, ELF3, IRF7, IRF8, FBP1, AURKB, TBX21, SERPINE1, PHB2, MYB, HOXA2, HOXA7, JUNB, MED1, DAPK1, HOXB4, HOXB3, SERPING1, PRDM16, ELANE, BARD1, FZD1, NDFIP2, PLK1, FZD8, UPF3B, SNAI2, CDKN1A, BTG2, HAVCR2, PAWR, PAX5, PAX2, AES, TAL1, RARA, GAS1, HCLS1, PLCB1, ENG, NR1I2, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, FMR1, TNF, DACH1, MEN1, TLE4, MAP2K2, IGFBP5, AEBP1, NACC2, WFS1, LSM5, LSM3, DAB2, BCL6, CNOT3, BCL3, PTPN22, EMILIN1, CR1, RFC1, PTBP2, XCL1, CEBPA, CEBPB, HDAC2, NLRC4, RBBP8, ZNF503, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, ZNF608, EDNRB, PPP2R1A, MAGOH, DPF3, SOX7, SOX4, IL1R2, RUNX2, TWIST1, BCL11A, IFNA2, XPO1, HBZ, EDN1, PARP9, CBFA2T3, NME1, MDFIC, SP100, TYMS, AIF1, PURA, CDX2, MLH1, LILRB4, ARID4A, CHCHD3, BASP1, TGFB2, TGFB1, CBX4, EIF2S1, NR4A2, LIN28A, NR4A3, CREBZF, KLF12, H2AFX, IFNG, PFDN5, LEF1, THBS1, SNCA, MEIS2, RBMX]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, LTA, LTB, BIRC2, BIRC3, TNFRSF11A, TNFRSF17, TNFSF14, TNFSF12, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, CD27, LTBR]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[, CDC20, TRIM25, SKP2, CDC34, PLK1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PCNP, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PSMD14, UBR1, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, BIRC2, RNF6, AURKB, ZNRF1, TBX21, RNF24, PML]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, ICAM1, SESN3, LAMP2, SKP2, POSTN, CYBB, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, LYN, JUN, EIF2AK2, EIF2S1, NR4A2, COL1A1, BCL2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, AIF1, FYN, NR1H4, SIPA1, FOXA3, FOXA2]
GO:0097178;ruffle assembly;6.0;1.0;0.8231203125901445;9.628524252492122;77.5241744012752;7.379178354882098;0.0025946643499833917;0.7004918368257019;[AIF1]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[ITGB5, IFI30, CD36, FCGR1A, FCGR1B, FCER1G, CHUK, HLA-B, TAP1, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, RBM38, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DAB2, COPS5, MAFB, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RPS6KB1, RBMX]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, RIPK2, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36, AIF1]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, TNC, AQP1, ICAM1, RUVBL2, AKT1, PRKACB, JUNB, PTGDR, MEN1, GHSR, MED1, LHCGR, MEF2C, PRKCE, PRKCD, LMO2, ADCYAP1, POR, ADCY9, RAB31, PRKAR1B, SIK1, FECH, ABCB4, SLC30A10, GATA1, FOXO1, SOCS2, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, KIF18A, NR4A3, FBN1, ROBO2, CTSS, GHR, CTSH, CTSB, IL10, EDN1, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CCNA2, CEACAM1, KIT, PTGER2, AIF1, P2RY6, PAK1, SPP1, FYN, CSK, SORBS1, POU4F1, TSHR, RPS6KB1, FOSB, RAMP1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, PDE4D, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0016046;detection of fungus;6.0;0.8653626801206646;0.7558016526504768;9.474373572664863;96.01252026694556;9.777073627680469;0.0032134526476763577;0.8231203125901445;[TLR4]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, RIPK2, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, CARD9, LILRB2, MAPK13, IL6, F2RL1, MYD88, IL17A]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, C2, PYCARD, C3, STAP1, CCL2, SIRPA, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, F2RL1, PTX3, FCGR2B, DOCK2]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, EMP2, ATP1B1, ANK1, RAB31, PKP3, TSPAN33, PRKCZ, EPB41L3, FLNA, TSPAN5, JUP, KCNIP4, TSPAN15, EHD3, RAMP1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, UBR1, SOCS2, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC2, BIRC3, UHRF1, NLRC4, ZNRF1, RNF24, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, PCNP, NEDD4, KLHL14, DTX3, UBE2C, UBE2M, TNFAIP3, UBE2Q2, HIST1H2BK, RNF6]
GO:0090630;activation of GTPase activity;7.0;1.0;0.8509193652572005;9.628524252492122;49.337455126924546;5.2552850506314295;0.0016512802222712962;0.6196748871422394;[CXCL13, RASGRP1, NTF3, CCR7, ECT2, EVI5, CCL21, RHOG, TBC1D8, TBC1D9, TBCK, EPHA2]
GO:1903223;positive regulation of oxidative stress-induced neuron death;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;363.38011971363295;8.390779266560578;0.012162005585939545;0.8253454670833372;[TLR6, TLR4]
GO:1904037;positive regulation of epithelial cell apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;105.42595785554589;6.375876246018314;0.0035285119322230004;0.701062607729944;[CD40, GSN, ITGA4, SORT1, FASLG, ARRB2, EIF2S1, THBS1, SFRP4, IL6, CD40LG, CCL2, PLCG1]
GO:0048741;skeletal muscle fiber development;7.0;1.0;0.8509193652572005;9.628524252492122;69.27622651621293;6.558197802812269;0.0023186129569415337;0.6863059058804069;[XK, GPX1, CAV2]
GO:0043330;response to exogenous dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;30.956451235720028;5.970411137910149;0.0010360845638621964;0.6284474158353811;[IFNA5, COLEC12, IFNA4, IFNA7, IFNA14, IFNA16, DDX58, RIPK2, CAV1, IFNA2, CARD9, IRAK3, IFIT1, IFNA8, NFKBIA, IFIH1, IFNA21, IFNA10]
GO:0045076;regulation of interleukin-2 biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;155.28197644939593;6.8867018697843045;0.005197148007055472;0.7031056191423581;[CD86, LAG3, CD80, CARD9, CD3E, IL1A, CD4, IL1B, CD28, PRKCQ, CARD11]
GO:0009609;response to symbiotic bacterium;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;57.42597956597373;9.083926447120524;0.0019219958560468828;0.7876727335416686;[GPX1, PTAFR]
GO:0060071;Wnt signaling pathway, planar cell polarity pathway;9.0;0.7436939687323844;0.7680876095464813;9.094441766561864;99.0414819593438;5.825829909099042;0.0033148292696323837;0.694173837660411;[ARRB2, CELSR1, AP2M1, CTHRC1, FZD1, FZD5, VANGL1, SFRP2, PFN1]
GO:2000573;positive regulation of DNA biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.427853557029971;748.2879117532506;5.618190544320798;0.02504452299098255;0.6623145257091445;[ARRB2, AURKB, CCT8, CCT7, CCT5, CCT4, RFC5, PDGFRB, CCT3, CCT2, RFC3, RFC4, RFC2, NEK7, KLF4, GRHL2, CCT6A, GREM1, NOX4, PRKCQ]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCB, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, SAMSN1, C2, C3, KLRK1, C7, PLCG2, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, DUSP3, ARG1, IFNGR1, RIPK2, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, NRAS, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ARRB2, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, GPX1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, BIRC2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, GFI1, ICAM2, ICAM3, ICAM1, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, CD48, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, RELB, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, LILRB4, CD40LG, F2RL1, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, LPXN, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, NFKBID, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, PDE4D, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4, TNIP3]
GO:0032226;positive regulation of synaptic transmission, dopaminergic;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;135.83014596643335;7.8311634786251565;0.004546112746301595;0.7754860644832351;[ARRB2, DRD4]
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.8311634786251565;0.011871713162238609;0.7967266896635242;[LY96, CD14, TLR4]
GO:0010572;positive regulation of platelet activation;9.0;0.8933024483968273;0.8428918493787028;9.592156608321247;334.5200598726648;8.16763571524637;0.011196085355429928;0.8139338954918922;[SELP, PDPN, PLEK, TLR4]
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;8.16763571524637;0.0018993574991869968;0.7408135829017477;[CD36, TLR6, TLR4, MYD88]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, IL23A, BPI, TLR4, LTF]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANXA1, KCNA5, CDC6, AIF1, CDC45, PLCB1]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[LYN, LY96, TNFAIP3, IRAK3, ARRB2, LILRA2, F2RL1, TLR6, CD14, TLR4, LGR4]
GO:0006195;purine nucleotide catabolic process;9.0;0.6835726970475526;0.7380269737040654;9.230494122871475;1844.4909477158026;6.039404009397101;0.06173345208596701;0.705096027081865;[GPX1, PDE4D, SAMHD1, NT5E, PDE4B, PDE5A]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[GSN, ARHGAP6, AIF1, VIL1, HCLS1, WASF3]
GO:0009620;response to fungus;5.0;0.7586651285174919;0.6695735761196662;9.089527751759436;27.267803904038782;5.926926025970411;9.126288572378991E-4;0.5933442844592942;[TGFB1, DEFA4, CARD9, DEFA1, MPO, GNLY, S100A12, CTSG, PTX3, TLR4, S100A9, ELANE, S100A8, LTF, IL17A]
GO:0002031;G-protein coupled receptor internalization;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;66.79409571189065;7.379178354882098;0.0022355382726935618;0.7523715242355574;[ADM, ARRB1, ARRB2, DNM2]
GO:0002032;desensitization of G-protein coupled receptor protein signaling pathway by arrestin;9.0;1.0;0.896240625180289;9.628524252492122;416.97188309209935;9.083926447120524;0.013955673676761097;0.8607930461318132;[ADRB2, ARRB2]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[CYFIP1, CD3G, IGHG1, FCGR3A, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, NR4A3, CD247, FCGR2B, IGKV3-20]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[CSF1R, TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, GAB2, MAPK14, TNF, OSCAR, TYROBP, TNFSF11, JUNB, EPHA2]
GO:0045084;positive regulation of interleukin-12 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;8.16763571524637;0.027942676825076673;0.7926932703116032;[LTB, TLR4]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CD80, GFI1, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, ICAM1, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, PDE4D, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, IRF8, TLR4, CX3CR1, CD274, CEBPB, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, TNIP3, PF4]
GO:0019372;lipoxygenase pathway;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;153.6575605806622;7.138016298065211;0.005142780269808322;0.7400384854347593;[GPX1, ALOX5, ALOX12, PTGS2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[MGST1, GPX1, EEF1G, NAT8]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[IL1RN, NCF1, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, RIPK2, MDFIC, IL1B, TLR6, PLCB1, TNFRSF11A, NOD2, RASGRP1, PAK1, CCL19, SLAMF1, FZD5, CCL21, CARD9, FZD8, CD40LG, CD27, F2RL1, PKN1, LTBR, FCGR2B, NOX1]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, ARRB1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP3, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, ICAM1, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, RIPK2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, F2RL1, TEK]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[NCF1, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, DAPK1, TPM1, PRKCD, CYBB, FANCD2, BTK, MGST1, FOXO1, PDGFD, ECT2, JUN, EIF2S1, NR4A2, IL6, CDK1, NOX4, EZH2, LRRK2, TNFAIP3, PTPRK, CD36, GPX2, ANXA1, GPX1, CHUK, ARG1, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, HDAC2, PCNA, AIF1, CST3, SNCA, KLF4, SOD2, MAPK13, FABP1]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[ABCA1, F2RL1, NLRC4, CD36, TLR6, TLR4]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, ARRB2, THBS1, NFKB1, TLR8, TIGIT, JAK3, SLAMF1]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL2, XCL1, IRF8, TLR4, TLR2, CCL13, STXBP2, AIF1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, RPS6KB1, ZYX]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
